Parkinson's disease

Active Ingredient: Rotigotine

Indication for Rotigotine

Population group: only adults (18 years old or older)
Therapeutic intent: Curative procedure

Rotigotine is indicated for the treatment of the signs and symptoms of early-stage idiopathic Parkinson’s disease as monotherapy (i.e. without levodopa).

For this indication, competent medicine agencies globally authorize below treatments:

2 mg/24 h once daily and then increased in weekly increments of 2 mg/24 h to a maximum dose of 8 mg/24 h

For:

Dosage regimens

Transdermal, 2 milligrams rotigotine, daily, over the duration of 1 week. Afterwards, transdermal, 4 milligrams rotigotine, daily, over the duration of 1 week. Afterwards, transdermal, 6 milligrams rotigotine, daily, over the duration of 1 week. Afterwards, transdermal, 8 milligrams rotigotine, daily. The maximum allowed total dose is 8 milligrams rotigotine daily.

Detailed description

Dosing in patients with early-stage Parkinson’s disease

A single daily dose should be initiated at 2 mg/24 h and then increased in weekly increments of 2 mg/24 h to an effective dose up to a maximum dose of 8 mg/24 h. 4 mg/24 h may be an effective dose in some patients. For most patients an effective dose is reached within 3 or 4 weeks at doses of 6 mg/24 h or 8 mg/24 h, respectively.

The maximum dose is 8 mg/24 h.

Treatment discontinuation

Rotigotine should be discontinued gradually. The daily dose should be reduced in steps of 2 mg/24 h with a dose reduction preferably every other day, until complete withdrawal of rotigotine.

Dosage considerations

The patch should be applied to clean, dry, intact healthy skin on the abdomen, thigh, hip, flank, shoulder, or upper arm. Reapplication to the same site within 14 days should be avoided. The patch should not be placed on skin that is red, irritated or damaged.

Active ingredient

Rotigotine

Rotigotine is a non-ergolinic dopamine agonist for the treatment of signs and symptoms of Parkinson’s disease and Restless Legs Syndrome.

Read more about Rotigotine

Related medicines

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner

Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.